The Washington CCP Opioid Progress Report Chronic, Non-Cancer Pain and Treatment Agreement is a document created by the Washington State Department of Health and the Washington State Pharmacy Board. The document outlines standards and expectations for the appropriate use of opioids in the treatment of chronic, non-cancer pain. It is intended to help health care providers, pharmacists, and patients understand the risks associated with opioid use and ensure safe and effective use of opioids. The document identifies different types of treatment agreements, including: provider treatment agreements; patient treatment agreements; and pharmacy treatment agreements. It outlines the responsibilities of each party involved in the agreement and provides guidelines for monitoring opioid use. It also outlines the process for reporting any adverse events or incidents.
Washington CVCP Opioid Progress Report Chronic, Non-Cancer Pain and Treatment Agreement.
Description
Form popularity
FAQ
A law in Washington State requires doctors to refer patients taking high doses of opioids for evaluation by a pain specialist if their underlying condition does not improve. The law passed last year is aimed at reducing the epidemic of prescription drug abuse.
This six-step approach to prescribing suggests that the physician should (1) evaluate and clearly define the patient's problem; (2) specify the therapeutic objective; (3) select the appropriate drug therapy; (4) initiate therapy with appropriate details and consider nonpharmacologic therapies; (5) give information,
Chronic non-cancer pain (CNCP) can be typically described as moderate or severe pain that lasts for six or more months and is attributed to conditions such as neuropathic pain, rheumatoid arthritis, lower back pain, osteoarthritis, fibromyalgia and a range of several other conditions 2.
Staying aware of your patient rights: Your physician is allowed to deny you a prescription for pain medication, but you also have the right to learn about your other treatment options and choose the option best suited to your needs.
Acute Prescribing The limits are: No more than 18 doses (approximately a 3-day supply) for patients age 20 or younger. No more than 42 doses (approximately a 7-day supply) for patients age 21 or older.
A treatment agreement is a document signed by a healthcare provider and a patient who is prescribed an opioid medication. The purpose of the treatment agreement is to help you and your healthcare provider work together toward safe and effective pain management and to avoid potential adverse issues.
For patients with chronic noncancer pain who are beginning opioid therapy, we recommend restricting the prescribed dose to less than 90 mg MED, rather than having no upper limit or a higher limit on dosing (strong recommendation). We suggest restricting the prescribed dose to less than 50 mg MED (weak recommendation).
Prescriptions must be for a legitimate medical purpose. There must be a valid ?provider, patient, client? relationship. Drugs must be within the provider's scope of practice.